Here, we performed a meta-analysis focusing on PAD patients who hadbeen treated with an infusion of BMMNCs, bone marrow-derived mesenchymal stem cells (BMMSCs), granulocyte colony-stimulating factormobilized peripheral blood mononuclear cells (G-CSF PBMCs), or peripheral blood-derivedstemcells(VesCell). Here, CSF3 is linked to peripheral arterial disease.